Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Recruiting 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Motor Activity 9Neoplasms 4Breast Neoplasms 3Weight Loss 2Ventricular Dysfunction, Left 1Urinary Incontinence 1Sexual Dysfunction, Physiological 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Melanoma 1Lymphoma 1Leukemia 1Insulin Resistance 1Hypoxia 1Hematologic Neoplasms 1Heart Failure 1Head and Neck Neoplasms 1Fecal Incontinence 1Fatigue 1Cardiotoxicity 1Carcinoma, Renal Cell 1Cachexia 1Brenner Tumor 1Breast Diseases 1Brain Neoplasms 1Bone Metastases 1Body Weight 1

Interventions

Cisplatin 30Radiotherapy 24pembrolizumab 21Cetuximab 21Docetaxel 13Fluorouracil 12Radiotherapy, Intensity-Modulated 10Paclitaxel 9Radiation 8Nivolumab 7Everolimus 7Carboplatin 7Oxaliplatin 6Gemcitabine 5Surgical Procedures, Operative 4Radiosurgery 4Magnetic Resonance Spectroscopy 4Gefitinib 4Erlotinib Hydrochloride 4Amifostine 4Pemetrexed 3Filgrastim 3Capecitabine 3Bleomycin 3Biopsy 3zalutumumab 2spartalizumab 2pegfilgrastim 2niraparib 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Head and Neck Neoplasms × Exercise × Clear all
NCT02557529 2020-05-27

Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy

Herlev Hospital

Phase NA Terminated
50 enrolled
Head & Neck

Head and Neck Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡